ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

24,859Medicare Part D Prescriptions Filled, Including Refills

Rank: 26 out of 4623

$1.74M Total Retail Price of All Prescriptions

Rank: 21 out of 4623

773 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
90% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 773 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

28% of this provider’s 773 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 20,452 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$70 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
DONEPEZIL HCL 809 743 1 30
HYDROCODONE-ACETAMINOPHEN 801 555 S3 2 3
LEVOTHYROXINE SODIUM 729 632 3 1
FUROSEMIDE 728 658 4 8
NAMENDA 698 627 5 36
SIMVASTATIN 611 490 6 2
LISINOPRIL 519 438 7 4
LANTUS 495 446 8 44
OMEPRAZOLE 482 400 9 7
WARFARIN SODIUM 481 452 10 24
DIVALPROEX SODIUM 476 407 11 90
AMLODIPINE BESYLATE 474 418 12 5
METOPROLOL TARTRATE 452 388 13 9
MIRTAZAPINE 407 370 14 57
GABAPENTIN 403 330 15 16
NOVOLIN R 389 362 16 113
CARVEDILOL 334 288 17 25
METFORMIN HCL 301 247 18 6
METOPROLOL SUCCINATE 287 262 19 13
ATORVASTATIN CALCIUM 285 246 20 12
RISPERIDONE 252 211 21 72
LACTULOSE 244 176 22 106
TRAMADOL HCL 244 205 22 15
SERTRALINE HCL 235 181 24 26
POTASSIUM CHLORIDE 233 215 25 14
CYMBALTA 228 164 26 48
GLIPIZIDE 218 155 27 49
CITALOPRAM HBR 216 170 28 23
ZOLPIDEM TARTRATE 213 149 29 18
EXELON 196 170 30 107
QUETIAPINE FUMARATE 186 152 31 74
TRAZODONE HCL 179 136 32 42
TAMSULOSIN HCL 163 160 33 29
DIOVAN 159 144 34 39
POLYETHYLENE GLYCOL 3350 159 141 34 91
ALBUTEROL SULFATE 154 150 36 142
MELOXICAM 154 124 36 27
OXYBUTYNIN CHLORIDE ER 147 122 38 163
KLOR-CON M20 144 137 39 102
NEXIUM 144 97 39 17
AMLODIPINE BESYLATE-BENAZEPRIL 143 119 41 55
DIVALPROEX SODIUM ER 140 111 42 148
BENZTROPINE MESYLATE 139 88 R 43 141
ALENDRONATE SODIUM 138 135 44 22
CLOPIDOGREL 136 112 45 31
ADVAIR DISKUS 131 91 46 62
LISINOPRIL-HYDROCHLOROTHIAZIDE 128 103 47 19
JANUVIA 128 104 47 52
CRESTOR 127 92 49 20
PANTOPRAZOLE SODIUM 126 97 50 35
RANITIDINE HCL 125 116 51 47
METHYLPREDNISOLONE 125 99 51 103
LYRICA 124 72 53 66
CLONIDINE HCL 120 85 54 40
LEVOFLOXACIN 116 99 55 81
PROMETHAZINE HCL 113 55 R 56 93
AZITHROMYCIN 112 88 57 33
NITROFURANTOIN MONO-MACRO 111 97 58 172
CARBIDOPA-LEVODOPA 109 106 59 116
PREDNISONE 108 69 60 50
ESCITALOPRAM OXALATE 107 100 61 75
ABILIFY 106 89 62 161
GLYBURIDE-METFORMIN HCL 105 63 R 63 56
CELEBREX 104 98 64 89
PHENYTOIN SODIUM EXTENDED 104 75 64 119
FLUTICASONE PROPIONATE 101 71 66 32
HYDROCHLOROTHIAZIDE 100 75 67 10
RISPERDAL CONSTA 99 97 68 313
DIGOXIN 99 91 68 58
FENTANYL 93 88 S2 70 118
FAMOTIDINE 90 67 71 82
SULFAMETHOXAZOLE-TRIMETHOPRIM 90 72 71 68
GENERLAC 87 80 73 240
VALPROIC ACID 87 77 73 229
CYCLOBENZAPRINE HCL 87 74 R 73 53
LOVASTATIN 86 76 76 34
LOSARTAN POTASSIUM 86 64 76 21
CEFTRIAXONE 81 77 78 262
SEROQUEL 81 68 78 149
GENTAMICIN SULFATE 80 72 80 278
OLANZAPINE 79 70 81 127
MUPIROCIN 79 59 81 159
SPIRIVA 78 75 83 79
PLAVIX 74 64 84 45
LEVETIRACETAM 72 51 85 114
IBUPROFEN 72 40 85 65
CIPROFLOXACIN HCL 71 58 87 43
TRIAMCINOLONE ACETONIDE 71 45 87 124
ALLOPURINOL 71 50 87 37
AGGRENOX 70 70 90 198
BACLOFEN 68 54 91 133
SINGULAIR 68 53 91 83
ACETAMINOPHEN-CODEINE 65 49 S3 93 144
GLIPIZIDE ER 65 62 93 86
PRAVASTATIN SODIUM 64 51 95 11
KLOR-CON M10 63 53 96 137
OXYBUTYNIN CHLORIDE 63 53 96 120
CARISOPRODOL 62 13 R 98 71
METOCLOPRAMIDE HCL 60 50 99 126
PHENYTOIN 59 51 100 294
SPIRONOLACTONE 59 28 100 77
NYSTATIN 58 54 102 175
LIDODERM 58 54 102 139
ISOSORBIDE MONONITRATE ER 58 58 102 60
NYSTOP 57 50 105 432
ACTOS 56 47 106 87
CEFUROXIME 56 44 106 152
FINASTERIDE 56 52 106 109
HYDROXYZINE HCL 55 38 R 109 138
METOLAZONE 55 39 109 208
PATANOL 54 54 111 254
VESICARE 54 46 111 166
CEPHALEXIN 54 49 111 84
VIGAMOX 53 51 114 541
GLYBURIDE 52 39 R 115 59
AMITRIPTYLINE HCL 52 41 R 115 69
HUMULIN R 50 49 117 252
MEGESTROL ACETATE 50 50 R 117 145
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 15, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.